34272978|t|Risk of intracranial haemorrhage and ischaemic stroke after convexity subarachnoid haemorrhage in cerebral amyloid angiopathy: international individual patient data pooled analysis.
34272978|a|OBJECTIVE: To investigate the frequency, time-course and predictors of intracerebral haemorrhage (ICH), recurrent convexity subarachnoid haemorrhage (cSAH), and ischemic stroke after cSAH associated with cerebral amyloid angiopathy (CAA). METHODS: We performed a systematic review and international individual patient-data pooled analysis in patients with cSAH associated with probable or possible CAA diagnosed on baseline MRI using the modified Boston criteria. We used Cox proportional hazards models with a frailty term to account for between-cohort differences. RESULTS: We included 190 patients (mean age 74.5 years; 45.3% female) from 13 centers with 385 patient-years of follow-up (median 1.4 years). The risks of each outcome (per patient-year) were: ICH 13.2% (95% CI 9.9-17.4); recurrent cSAH 11.1% (95% CI 7.9-15.2); combined ICH, cSAH, or both 21.4% (95% CI 16.7-26.9), ischemic stroke 5.1% (95% CI 3.1-8) and death 8.3% (95% CI 5.6-11.8). In multivariable models, there is evidence that patients with probable CAA (compared to possible CAA) had a higher risk of ICH (HR 8.45, 95% CI 1.13-75.5, p = 0.02) and cSAH (HR 3.66, 95% CI 0.84-15.9, p = 0.08) but not ischemic stroke (HR 0.56, 95% CI 0.17-1.82, p = 0.33) or mortality (HR 0.54, 95% CI 0.16-1.78, p = 0.31). CONCLUSIONS: Patients with cSAH associated with probable or possible CAA have high risk of future ICH and recurrent cSAH. Convexity SAH associated with probable (vs possible) CAA is associated with increased risk of ICH, and cSAH but not ischemic stroke. Our data provide precise risk estimates for key vascular events after cSAH associated with CAA which can inform management decisions.
34272978	8	32	intracranial haemorrhage	Disease	MESH:D013345
34272978	37	53	ischaemic stroke	Disease	MESH:D002544
34272978	60	69	convexity	Disease	MESH:D005413
34272978	70	94	subarachnoid haemorrhage	Disease	MESH:D013345
34272978	98	125	cerebral amyloid angiopathy	Disease	MESH:D016657
34272978	152	159	patient	Species	9606
34272978	253	278	intracerebral haemorrhage	Disease	MESH:D002543
34272978	280	283	ICH	Disease	MESH:D002543
34272978	296	305	convexity	Disease	MESH:D005413
34272978	306	330	subarachnoid haemorrhage	Disease	MESH:D013345
34272978	332	336	cSAH	Disease	MESH:D013345
34272978	343	358	ischemic stroke	Disease	MESH:D002544
34272978	365	369	cSAH	Disease	MESH:D013345
34272978	386	413	cerebral amyloid angiopathy	Disease	MESH:D016657
34272978	415	418	CAA	Disease	MESH:D016657
34272978	492	499	patient	Species	9606
34272978	524	532	patients	Species	9606
34272978	538	542	cSAH	Disease	MESH:D013345
34272978	580	583	CAA	Disease	MESH:D016657
34272978	774	782	patients	Species	9606
34272978	844	851	patient	Species	9606
34272978	922	929	patient	Species	9606
34272978	942	945	ICH	Disease	MESH:D002543
34272978	981	985	cSAH	Disease	MESH:D013345
34272978	1020	1023	ICH	Disease	MESH:D002543
34272978	1025	1029	cSAH	Disease	MESH:D013345
34272978	1065	1080	ischemic stroke	Disease	MESH:D002544
34272978	1105	1110	death	Disease	MESH:D003643
34272978	1183	1191	patients	Species	9606
34272978	1206	1209	CAA	Disease	MESH:D016657
34272978	1232	1235	CAA	Disease	MESH:D016657
34272978	1258	1261	ICH	Disease	MESH:D002543
34272978	1304	1308	cSAH	Disease	MESH:D013345
34272978	1355	1370	ischemic stroke	Disease	MESH:D002544
34272978	1474	1482	Patients	Species	9606
34272978	1488	1492	cSAH	Disease	MESH:D013345
34272978	1530	1533	CAA	Disease	MESH:D016657
34272978	1559	1562	ICH	Disease	MESH:D002543
34272978	1577	1581	cSAH	Disease	MESH:D013345
34272978	1583	1592	Convexity	Disease	MESH:D005413
34272978	1593	1596	SAH	Disease	MESH:D013345
34272978	1636	1639	CAA	Disease	MESH:D016657
34272978	1677	1680	ICH	Disease	MESH:D002543
34272978	1686	1690	cSAH	Disease	MESH:D013345
34272978	1699	1714	ischemic stroke	Disease	MESH:D002544
34272978	1786	1790	cSAH	Disease	MESH:D013345
34272978	1807	1810	CAA	Disease	MESH:D016657

